Article Text

PDF
THU0478 Determination of comorbidities in fibromyalgia syndrome
  1. U Bilge1,
  2. T Kaşifoğlu2,
  3. NS Yaşar Bilge2,
  4. H Balcıoğlu1,
  5. YE Sarı1,
  6. M Kayhan1,
  7. I Ünlüoğlu1
  1. 1Eskişehir Osmangazi University Faculty of Medicine Department of Family Medicine, Eskişehir Osmangazi University Faculty of Medicine Department of Family Medicine
  2. 2Eskişehir Osmangazi University, Eskişehir Osmangazi University Faculty of Medicine Department of Internal Medicine Division of Rheumatology, Eskişehir, Turkey

Abstract

Background Although fibromyalgia syndrome is diagnosed by excluding other possible diagnosis based on the patient's clinical features, in recent the studies, it was shown that comorbid diseases affect the course of fibromyalgia.

Objectives The aim of this study is to evaluate the comorbid diseases of patients with fibromyalgia and to determine the rates of comorbid diseases

Methods In this study, age, gender and comorbid diseases of patients above 18 years and diagnosed with fibromyalgia by a were evaluated in the database system of the hospital retrospectively.

Results A total of 509 patients were examined in our study. 51 of the patients were male, 458 were female (mean age was 50.24±12.32). Of the patients, 345 (67.8%) had at least one comorbid disease while 164 (32.2%) had no comorbid disease. In the study, 187 of the patients (36.7%) had cardiovascular diseases, 157 of the patients (30.8%) had endocrine diseases, 63 of the patients (12.4%) had rheumatologic diseases, 30 of the patients (5.9%) had neurological diseases, 14 of the patients (2.8%) had other autoimmune diseases, 10 of the patients (2.0%) had cancers, 129 of the patients (25.3%) had mental disorders, 45 of the patients (8.8%) had chronic lung diseases, 37 of the patients (7.3%) had osteoporosis, 11 of the patients (2.2%) had other diseases (chronic pancreatitis, chronic renal failure, nephrotic syndrome, deep vein thrombosis, hepatitis serology positivity, pulmonary thromboembolism, organ transplantation).

Conclusions FMS is an important disease that is increasing in frequency in recent years. FMS, which can be seen with many diseases, is in fact related to physicians from many branches, and it is useful to evaluate FMS patients with their comorbid conditions on their follow-up.

References

  1. Choy EH & Mease PJ. Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials). Rheumatic Disease Clinics of North America, 2009; 35(2):329–337.

  2. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis & Rheumatism, 1990; 33(2):160–172.

  3. Soran N, Altındağ Ö, Demirkol A, Sallı A, Yılmaz H, Kocabaş H, et al. Depression level and relation with clinical parameters in fibromyalgia syndrome. Rheumatism, 2008; 23:1–4.

References

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.